Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_assertion type Assertion NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_head.
- NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_assertion description "[We further showed that both atypical endometriosis and adjacent CCC had loss of BAF250a expression (38.5% vs. 57.7%), HNF-1b up-regulation (53.8% vs. 92.3%), and loss of ER (84.6% vs. 92.3%) and PR (76.9% vs. 84.6%) expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_provenance.
- NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_assertion evidence source_evidence_literature NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_provenance.
- NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_assertion SIO_000772 22977660 NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_provenance.
- NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_assertion wasDerivedFrom befree-2016 NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_provenance.
- NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_assertion wasGeneratedBy ECO_0000203 NP1012933.RA-JqCP6NUeaWq4o2j7frlcQTmdM5SqLwEB72pP5WCFSE130_provenance.